Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___	O
Chief	O
Complaint:	O
Syncope	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
1.	O
Celiac	O
and	O
splenic	O
artery	O
angiogram	O
with	O
interventional	O
radiology	O
2.	O
Placement	O
of	O
8mm	O
amplatzer	O
device	O
in	O
the	O
proximal	O
splenic	O
artery	O
with	O
interventional	O
radiology	O
History	O
of	O
Present	O
Illness:	O
Mr.	O
___	O
is	O
a	O
___	O
gentleman	O
with	O
a	O
metastatic	O
melanoma	O
with	O
lesions	O
to	O
the	O
brain	O
s/p	O
resection	O
and	O
radiation,	O
left	O
femur,	O
and	O
spleen	O
s/p	O
___	O
feducial	O
placement	O
on	O
___	O
who	O
presents	O
after	O
a	O
syncopal	O
episode	O
on	O
___.	O
He	O
had	O
been	O
in	O
his	O
usual	O
state	O
of	O
health	O
after	O
the	O
procedure	O
with	O
some	O
abdominal	O
soreness	O
but	O
no	O
significant	O
pain	O
or	O
lightheadedness/dizziness.	O
He	O
was	O
at	O
the	O
store	O
on	O
___	O
when	O
he	O
experienced	O
severe,	O
sudden	O
onset	O
bandlike	O
pain	O
across	O
his	O
upper	O
abdomen.	O
This	O
continued	O
for	O
a	O
few	O
minutes,	O
so	O
he	O
went	O
to	O
check	O
out	O
and	O
lost	O
consciousness	O
with	O
headstrike.	O
He	O
awoke	B-Falls
on	B-Falls
the	B-Falls
ground.	B-Falls
No	O
one	O
described	O
any	O
shaking	O
or	O
seizure	B-Seizures
like	O
activity	O
and	O
he	O
denies	O
tongue	O
biting	O
or	O
loss	B-Faecal_incontinence
of	B-Faecal_incontinence
bowel/bladder	I-Urinary_incontinence
control.	B-Urinary_incontinence
He	O
was	O
brought	O
to	O
___	O
___	O
where	O
he	O
was	O
hemodynamically	O
stable	O
with	O
negative	O
head	O
CT.	O
CT	O
of	O
the	O
abdomen	O
notable	O
for	O
splenic	O
hematoma	O
and	O
he	O
was	O
transferred	O
to	O
___	O
for	O
definitive	O
care.	O
In	O
the	O
ED,	O
initial	O
vitals:	O
T	O
97.5,	O
HR	O
80,	O
BP	O
130/92,	O
RR	O
16,	O
SaO2	O
98%	O
RA.	O
-	O
Exam	O
notable	O
for:	O
AAOx3,	B-Delirium
benign	O
exam	O
-	O
Labs	O
notable	O
for:	O
___	O
H+H	O
___	O
05:47	O
H+H	O
9.0/26.9	O
___	O
H+H	O
8.6/25.5	O
UA	O
-	O
SpecGrav	O
1.037,	O
Prot	O
trace,	O
Gluc	O
300mg,	O
Ket	O
40,	O
Bacteria	O
Few	O
-	O
Imaging	O
notable	O
for:	O
CT	O
abdomen	O
showed	O
internal	O
progressive	O
enhancement	O
over	O
arterial	O
and	O
venous	O
phases,	O
without	O
definite	O
evidence	O
of	O
active	O
extravasation.	O
-	O
Pt	O
given:	O
Nothing	O
___	O
and	O
ACS	O
were	O
consulted,	O
and	O
___	O
management	O
was	O
preferred.	O
___	O
performed	O
celiac	O
and	O
then	O
splenic	O
angiogram,	O
and	O
there	O
was	O
no	O
evidence	O
of	O
active	O
extravasation.	O
Irregular	O
areas	O
in	O
spleen	O
were	O
noted,	O
possibly	O
the	O
known	O
lesions	O
concerning	O
for	O
mets.	O
Given	O
that	O
the	O
hematoma	O
showed	O
interval	O
increase	O
on	O
CT	O
today	O
compared	O
to	O
OSH	O
image	O
yesterday,	O
an	O
8mm	O
amplatzer	O
device	O
was	O
placed	O
in	O
the	O
proximal	O
splenic	O
artery	O
to	O
decrease	O
vascular	O
pressure	O
to	O
the	O
spleen.	O
On	O
the	O
floor,	O
patient	O
reports	O
feeling	O
well	O
and	O
complains	O
only	O
of	O
mild	O
cramping	O
LUQ	O
soreness	O
worse	O
with	O
deep	O
breaths.	O
He	O
denies	O
any	O
lightheadedness,	O
weakness,	O
dizziness.	O
He	O
also	O
denies	O
recent	O
fever/chills,	O
headaches,	O
changes	O
in	O
vision,	O
chest	O
pain,	O
dyspnea,	O
n/v/d,	O
dysuria,	O
myalgias,	O
arthalgias.	O
He	O
endorses	O
chronic	O
dry	O
cough	O
that's	O
at	O
baseline.	O
Past	O
Medical	O
History:	O
Metastatic	O
malignant	O
melanoma	O
-	O
Left	O
frontal	O
lobe	O
mass	O
s/p	O
craniotomy	O
___	O
-	O
Lesion	O
in	O
left	O
femur	O
-	O
Enlarging	O
lesion	O
in	O
spleen,	O
s/p	O
feducials	O
___	O
-	O
He	O
was	O
receiving	O
palliative	O
nivolumab,	O
but	O
stopped	O
due	O
to	O
pulmonary	O
side	O
effects	O
(?pneumonia)	O
Diabetes	O
mellitus	O
type	O
2	O
Diabetic	O
retinopathy	O
[E11.319]	O
Macular	O
edema	O
due	O
to	O
secondary	O
diabetes	O
Hypertension	O
Hyperlipidemia	O
Benign	O
prostatic	O
hyperplasia	O
Extranodal	O
marginal	O
zone	O
B-cell	O
lymphoma	O
Social	O
History:	O
___	O
Family	O
History:	O
Brother	O
with	O
CAD/PVD	O
Father	O
deceased	O
from	O
prostate	O
cancer	O
Mother	O
and	O
sister	O
with	O
Type	O
2	O
Diabetes	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
Vitals:	O
97.8,	O
151/65,	O
75,	O
16,	O
97%	O
RA	O
General:	O
Alert,	O
oriented,	B-Delirium
no	O
acute	O
distress	O
HEENT:	O
Sclerae	O
anicteric,	O
MMM,	O
oropharynx	O
clear	O
Neck:	O
no	O
c-spine	O
tenderness	O
Lungs:	O
CTAB	O
no	O
wheezes,	O
rales,	O
rhonchi	O
CV:	O
RRR,	O
Nl	O
S1,	O
S2,	O
No	O
MRG	O
Abdomen:	O
soft,	O
NT/ND	O
bowel	O
sounds	O
present	O
GU:	O
no	O
foley	O
Ext:	O
warm,	O
well	O
perfused,	O
2+	O
pulses,	O
no	O
edema	O
Neuro:	O
CN2-12	O
intact,	O
___	O
strength	O
in	O
b/l	O
upper	O
and	O
lower	O
extremities,	O
sensation	O
intact	O
Skin:	O
c/d/I	O
dressings	O
over	O
left	O
flank	O
and	O
right	O
inguinal	O
area.	O
No	O
e/o	O
active	O
bleeding	O
or	O
significant	O
oozing.	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
Vitals:	O
98.2,	O
79,	O
123/48,	O
18,	O
95%	O
RA	O
General:	O
Alert,	O
oriented,	B-Delirium
no	O
acute	O
distress	O
HEENT:	O
Sclerae	O
anicteric,	O
MMM,	O
oropharynx	O
clear	O
Lungs:	O
CTAB	O
no	O
wheezes,	O
rales,	O
rhonchi	O
CV:	O
RRR,	O
Nl	O
S1,	O
S2,	O
No	O
MRG	O
Abdomen:	O
soft,	O
ND,	O
bowel	O
sounds	O
present,	O
minimal	O
tenderness	O
in	O
RUQ	O
and	O
LUQ	O
GU:	O
No	O
foley	O
Ext:	O
Warm,	O
well	O
perfused,	O
2+	O
pulses,	O
no	O
edema	O
Neuro:	O
strength	O
and	O
sensation	O
grossly	O
intact	O
Skin:	O
c/d/I	O
dressings	O
over	O
left	O
flank	O
and	O
right	O
inguinal	O
area.	O
No	O
e/o	O
active	O
bleeding	O
or	O
significant	O
oozing.	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
___	O
11:30PM	O
BLOOD	O
WBC-9.9	O
RBC-3.24*	O
Hgb-9.4*	O
Hct-28.0*	O
MCV-86	O
MCH-29.0	O
MCHC-33.6	O
RDW-13.2	O
RDWSD-41.7	O
Plt	O
___	O
___	O
11:30PM	O
BLOOD	O
Neuts-79.6*	O
Lymphs-10.8*	O
Monos-8.4	O
Eos-0.3*	O
Baso-0.4	O
Im	O
___	O
AbsNeut-7.87*	O
AbsLymp-1.07*	O
AbsMono-0.83*	O
AbsEos-0.03*	O
AbsBaso-0.04	O
___	O
02:48AM	O
BLOOD	O
___	O
PTT-26.3	O
___	O
___	O
11:30PM	O
BLOOD	O
Glucose-176*	O
UreaN-15	O
Creat-0.6	O
Na-128*	O
K-4.5	O
Cl-91*	O
HCO3-25	O
AnGap-17	O
___	O
11:30PM	O
BLOOD	O
ALT-11	O
AST-14	O
AlkPhos-72	O
TotBili-0.4	O
___	O
11:30PM	O
BLOOD	O
Lipase-18	O
___	O
11:30PM	O
BLOOD	O
Albumin-3.7	O
___	O
10:10PM	O
BLOOD	O
Calcium-8.5	O
Phos-4.0	O
Mg-1.8	O
PERTINENT	O
LABS:	O
___	O
05:30AM	O
URINE	O
Color-Yellow	O
Appear-Clear	O
Sp	O
___	O
___	O
05:30AM	O
URINE	O
Blood-NEG	O
Nitrite-NEG	O
Protein-TR	O
Glucose-300	O
Ketone-40	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-6.0	O
Leuks-NEG	O
___	O
05:30AM	O
URINE	O
RBC-<1	O
WBC-0	O
Bacteri-FEW	O
Yeast-NONE	O
Epi-<1	O
___	O
05:30AM	O
URINE	O
Hours-RANDOM	O
Na-84	O
___	O
05:30AM	O
URINE	O
Osmolal-705	O
DISCHARGE	O
LABS:	O
___	O
07:41AM	O
BLOOD	O
WBC-10.5*	O
RBC-3.03*	O
Hgb-8.8*	O
Hct-26.0*	O
MCV-86	O
MCH-29.0	O
MCHC-33.8	O
RDW-13.4	O
RDWSD-41.9	O
Plt	O
___	O
___	O
07:41AM	O
BLOOD	O
___	O
PTT-27.7	O
___	O
___	O
07:41AM	O
BLOOD	O
Glucose-205*	O
UreaN-15	O
Creat-0.6	O
Na-128*	O
K-4.6	O
Cl-91*	O
HCO3-26	O
AnGap-16	O
___	O
07:41AM	O
BLOOD	O
Calcium-8.6	O
Phos-3.7	O
Mg-1.9	O
IMAGING:	O
___	O
CT	O
TORSO	O
1.	O
Status	O
post	O
placement	O
of	O
two	O
fiducial	O
seeds	O
adjacent	O
to	O
a	O
hypodense	O
splenic	O
metastasis.	O
2.	O
Interval	O
development	O
of	O
a	O
moderate-sized	O
subcapsular	O
splenic	O
hematoma.	O
3.	O
Moderate	O
amount	O
of	O
new	O
intermediate	O
density	O
intraperitoneal	O
free	O
fluid	O
may	O
represent	O
resolving	O
hemorrhagic	O
fluid.	O
4.	O
Subcapsular	O
areas	O
of	O
hypodensity	O
within	O
the	O
inferior	O
aspect	O
of	O
the	O
spleen	O
(?	O
Laceration)	O
are	O
most	O
consistent	O
with	O
sequela	O
of	O
recent	O
fiducial	O
placement.	O
5.	O
Heterogeneous	O
bibasilar	O
pulmonary	B-Lower_respiratory_tract_infection
opacities	O
appear	O
similar	O
to	O
___	O
and	O
may	O
represent	O
an	O
infectious	B-Lower_respiratory_tract_infection
or	O
inflammatory	O
process,	O
however	O
malignancy	O
is	O
not	O
excluded.	O
6.	O
Known	O
osseous	O
metastasis	O
in	O
the	O
subtrochanteric	O
left	O
femur	O
is	O
better	O
assessed	O
on	O
prior	O
PET-CT.	O
___	O
CTA	O
ABDOMEN/PELVIS	O
1.	O
Re-	O
demonstration	O
of	O
known	O
splenic	O
metastasis	O
with	O
two	O
adjacent	O
fiducial	O
seeds.	O
This	O
lesion	O
demonstrates	O
internal	O
progressive	O
enhancement	O
over	O
arterial	O
and	O
venous	O
phases,	O
without	O
definite	O
evidence	O
of	O
active	O
extravasation.	O
2.	O
Subcapsular	O
areas	O
of	O
hypodensity	O
within	O
the	O
inferior	O
aspect	O
of	O
the	O
spleen	O
(?	O
Laceration)	O
are	O
most	O
consistent	O
with	O
sequela	O
of	O
recent	O
fiducial	O
placement.	O
3.	O
Stable	O
heterogeneous	O
subcapsular	O
splenic	O
hematoma.	O
No	O
evidence	O
of	O
active	O
extravasation	O
into	O
the	O
subcapsular	O
hematoma.	O
4.	O
Moderate	O
volume	O
of	O
intra-abdominal	O
free	O
fluid	O
measures	O
hemorrhagic	O
density.	O
5.	O
Assessment	O
of	O
the	O
splenic	O
parenchyma	O
on	O
the	O
arterial	O
phase	O
is	O
limited	O
due	O
to	O
intrinsic	O
heterogeneous	O
splenic	O
enhancement.	O
Allowing	O
for	O
this	O
limitation,	O
there	O
is	O
no	O
definite	O
evidence	O
of	O
pseudoaneurysm.	O
6.	O
Heterogeneous	O
bibasilar	O
pulmonary	O
opacities	O
again	O
may	O
represent	O
an	O
infectious	O
or	O
inflammatory	O
process,	O
however	O
malignancy	O
is	O
not	O
excluded.	O
7.	O
Known	O
osseous	O
metastasis	O
in	O
the	O
subtrochanteric	O
left	O
femur	O
is	O
better	O
assessed	O
on	O
prior	O
PET-CT.	O
___	O
SPLENIC	O
ARTERIOGRAM	O
Successful	O
splenic	O
arterial	O
angiogram	O
without	O
discrete	O
evidence	O
of	O
active	O
extravasation.	O
However,	O
given	O
the	O
increasing	O
size	O
of	O
the	O
perisplenic	O
hematoma	O
on	O
the	O
concomitant	O
CT	O
scan	O
of	O
the	O
abdomen	O
and	O
pelvis,	O
an	O
Amplatzer	O
plug	O
was	O
deployed	O
to	O
decrease	O
pressures	O
to	O
the	O
presumed	O
location	O
of	O
hemorrhage.	O
Brief	O
Hospital	O
Course:	O
Mr.	O
___	O
is	O
a	O
___	O
gentleman	O
with	O
metastatic	O
melanoma	O
s/p	O
___	O
splenic	O
feducial	O
placement	O
on	O
___	O
who	O
presented	O
after	O
a	O
syncopal	O
episode	O
found	O
to	O
have	O
splenic	O
hematoma	O
who	O
underwent	O
___	O
amplatzer	O
device	O
placement.	O
#Splenic	O
hematoma:	O
He	O
was	O
hemodynamically	O
stable	O
with	O
a	O
stable	O
H/H	O
on	O
initial	O
presentation	O
to	O
the	O
ED.	O
CTA	O
and	O
celiac/splenic	O
angiogram	O
demonstrated	O
no	O
active	O
extravasation.	O
His	O
CT	O
on	O
___	O
showed	O
an	O
interval	O
increase	O
in	O
hematoma	O
size	O
and	O
intraperitoneal	O
fluid	O
compared	O
to	O
CT	O
on	O
___.	O
Given	O
this,	O
___	O
placed	O
an	O
8mm	O
amplatzer	O
device	O
in	O
the	O
proximal	O
splenic	O
artery.	O
His	O
dressing	O
over	O
the	O
catheterization	O
site	O
remained	O
clean,	O
dry	O
and	O
intact	O
without	O
tenderness	O
or	O
underlying	O
hematoma.	O
Serial	O
HRs,	O
blood	O
pressures,	O
and	O
hematocrits	O
were	O
stable.	O
He	O
endorsed	O
only	O
mild	O
abdominal	O
cramping	O
and	O
denied	O
any	O
dizziness/lightheadedness	O
at	O
discharge.	O
He	O
does	O
not	O
need	O
follow	O
up	O
with	O
interventional	O
radiology.	O
#Syncope:	O
Patient	O
had	O
a	O
syncopal	O
episode	O
at	O
the	O
hardware	O
store,	O
likely	O
vasovagal	O
secondary	O
to	O
sudden	O
onset	O
of	O
pain.	O
There	O
were	O
no	O
prodromal	O
symptoms.	O
This	O
is	O
somewhat	O
concerning	O
for	O
an	O
arrhythmia,	O
though	O
the	O
patient	O
has	O
no	O
cardiac	O
history	O
and	O
denied	O
any	O
palpitations/chest	O
pain.	O
He	O
may	O
benefit	O
from	O
a	O
Holter	O
monitor	O
as	O
an	O
outpatient.	O
Orthostatic	O
syncope	O
is	O
less	O
likely	O
given	O
no	O
orthostatic	O
symptoms	O
or	O
recent	O
n/v/d.	O
No	O
observed	O
seizure	B-Seizures
activity,	O
post-ictal	B-Seizures
symptoms,	O
tongue	O
biting,	O
or	O
bowel/bladder	I-Urinary_incontinence
incontinence	B-Urinary_incontinence
to	O
raise	O
concern	O
for	O
seizure	B-Seizures
in	O
the	O
setting	O
of	O
brain	O
mets.	O
CT	O
head	B-Intracranial_haemorrhage
with	O
no	O
e/o	O
of	O
new	O
hemorrhage	B-Intracranial_haemorrhage
from	O
fall.	B-Falls
#Hyponatremia:	O
Sodium	O
128	O
on	O
admission,	O
with	O
elevated	O
urine	O
osms	O
(705)	O
and	O
urine	O
sodium	O
(84),	O
consistent	O
with	O
SIADH	O
likely	O
in	O
the	O
setting	O
of	O
his	O
known	O
malignancy.	O
His	O
sodium	O
was	O
stable	O
at	O
128	O
at	O
discharge.	O
Transitional	O
issues:	O
-Recommend	O
follow	O
up	O
with	O
PCP	O
to	O
discuss	O
recent	O
syncopal	O
episode	O
and	O
any	O
changes	O
in	O
plans	O
to	O
proceed	O
with	O
radiation	O
given	O
splenic	O
hematoma	O
-Recommend	O
outpatient	O
Holter	O
monitor	O
to	O
assess	O
for	O
any	O
arrhythmias	O
that	O
may	O
have	O
caused	O
his	O
syncope	O
-Patient	O
counseled	O
not	O
to	O
drive	O
for	O
6	O
weeks	O
following	O
syncopal	O
episode	O
in	O
accordance	O
with	O
___	O
law	O
-No	O
___	O
needed	O
with	O
interventional	O
radiology	O
-Hg	O
on	O
discharge:	O
8.8.	O
Recommend	O
repeating	O
CBC	O
at	O
PCP	O
___	O
visit.	O
-Patient	O
with	O
hyponatremia	O
with	O
Ulytes	O
consistent	O
with	O
SIADH.	O
He	O
was	O
discharged	O
on	O
a	O
fluid	O
resctrition.	O
Please	O
repeat	O
Na	O
at	O
PCP	O
___	O
visit	O
to	O
ensure	O
stability.	O
Na	O
128	O
on	O
discharge.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
MetFORMIN	O
(Glucophage)	O
850	O
mg	O
PO	O
DAILY	O
2.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
QHS	O
3.	O
Pravastatin	O
20	O
mg	O
PO	O
QPM	O
4.	O
amlodipine-benazepril	O
___	O
mg	O
oral	O
DAILY	O
5.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
amlodipine-benazepril	O
___	O
mg	O
oral	O
DAILY	O
2.	O
MetFORMIN	O
(Glucophage)	O
850	O
mg	O
PO	O
DAILY	O
3.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
4.	O
Pravastatin	O
20	O
mg	O
PO	O
QPM	O
5.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
QHS	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Primary:	O
Splenic	O
hematoma	O
Secondary:	O
Syncope,	O
metastatic	O
melanoma,	O
Type	O
2	O
diabetes,	O
Hypertension,	O
Hyperlipidemia	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
We	O
saw	O
your	O
in	O
the	O
hospital	O
because	O
you	O
lost	O
consciousness	O
in	O
the	O
hardware	O
store	O
and	O
were	O
found	O
to	O
have	O
some	O
bleeding	O
in	O
your	O
spleen.	O
The	O
bleeding	O
in	O
your	O
spleen	O
may	O
have	O
been	O
caused	O
by	O
the	O
radiation	O
beads	O
that	O
were	O
placed.	O
We	O
did	O
several	O
tests	O
that	O
showed	O
there	O
was	O
no	O
continued	O
bleeding	O
in	O
the	O
spleen.	O
The	O
interventional	O
radiology	O
team	O
placed	O
a	O
plug-like	O
device	O
(called	O
an	O
amplatzer	O
device)	O
in	O
the	O
blood	O
vessel	O
that	O
goes	O
to	O
your	O
spleen	O
to	O
help	O
reduce	O
the	O
blood	O
pressure	O
to	O
the	O
spleen.	O
This	O
will	O
help	O
prevent	O
any	O
new	O
or	O
additional	O
bleeding.	O
Your	O
blood	O
counts	O
remained	O
stable	O
after	O
the	O
procedure	O
and	O
you	O
felt	O
well.	O
We	O
think	O
you	O
lost	O
consciousness	O
due	O
to	O
the	O
sudden	O
severe	O
pain	O
that	O
you	O
felt.	O
You	O
had	O
a	O
CAT	O
scan	O
of	O
your	O
head	O
at	O
___	O
which	O
showed	O
there	O
was	O
no	O
bleeding	B-Intracranial_haemorrhage
in	O
your	O
brain	B-Intracranial_haemorrhage
after	O
you	O
hit	O
your	O
head.	O
The	O
state	O
of	O
___	O
stipulates	O
that	O
people	O
who	O
have	O
had	O
a	O
loss	O
of	O
consciousness	O
should	O
not	O
drive	O
for	O
6	O
months	O
after	O
their	O
episode,	O
because	O
there	O
is	O
a	O
risk	O
that	O
you	O
might	O
lose	O
consciousness	O
again	O
while	O
driving.	O
We	O
recommend	O
that	O
you	O
abide	O
by	O
this.	O
You	O
do	O
not	O
need	O
to	O
___	O
with	O
the	O
interventional	O
radiology	O
team	O
here.	O
You	O
should	O
follow	O
up	O
with	O
your	O
primary	O
care	O
doctor	O
to	O
touch	O
base	O
about	O
continuing	O
plans	O
for	O
radiation.	O
Your	O
sodium	O
level	O
was	O
slightly	O
low.	O
Please	O
limit	O
the	O
amount	O
of	O
fluid	O
you	O
take	O
in	O
to	O
less	O
than	O
1.5L	O
per	O
day.	O
Your	O
primary	O
care	O
physician	O
___	O
recheck	O
your	O
sodium	O
level	O
in	O
___.	O
It	O
was	O
a	O
pleasure	O
to	O
participate	O
in	O
your	O
care.	O
Sincerely,	O
Your	O
___	O
team	O
Followup	O
Instructions:	O
___	O

